Apolipoprotein E Genotypes Associated with Alzheimer Disease and Concomitant Stroke

被引:13
|
作者
Fekih-Mrissa, Najiba [1 ,2 ]
Klai, Sarra [1 ,3 ]
Mrad, Meriem [1 ,3 ]
Mansour, Malek [4 ,5 ]
Zaouali, Jamel [4 ,5 ]
Gritli, Nasreddine [1 ,6 ]
Mrissa, Ridha [4 ,5 ]
机构
[1] Hop Mil Principal Instruct Tunis, Serv Hematol, Mol Biol Lab, Tunis 1008, Tunisia
[2] Acad Mil Fondouk Jedid, Nabeul, Tunisia
[3] Univ Tunis El Manar, Fac Sci Tunis, El Manar, Tunisia
[4] Hop Mil Principal Instruct Tunis, Serv Neurol, Tunis 1008, Tunisia
[5] Univ Tunis El Manar, Fac Med Tunis, Tunis, Tunisia
[6] Univ Monastir, Fac Pharm, Monastir, Tunisia
来源
关键词
Apolipoprotein E; Alzheimer disease; stroke; risk factor; genotyping; E-POLYMORPHISM; ALLELE FREQUENCIES; VASCULAR RISK; APOE; PROGRESSION; METAANALYSIS; POPULATIONS; EPSILON-4; ONSET; BRAIN;
D O I
10.1016/j.jstrokecerebrovasdis.2013.06.018
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Background: The epsilon 4 allele of the apolipoprotein E (APOE) gene is a well-characterized genetic risk factor for Alzheimer disease (AD). The association between stroke and a higher risk for AD has also been reported. Our study sought to determine the relationship between the APOE gene and AD and the comorbid risk of stroke. Methods: The subjects of this study consisted of 48 patients with AD and 48 members of a control group. All subjects were genotyped for APOE. Results: The results clearly show a significant increased risk of AD in carriers of the APOE epsilon 3/epsilon 4 genotype (P = .003, odds ratio [OR] = 4.1) or epsilon 4 allele (P = .001, OR = 4.2). The risk for stroke in AD patients was also increased for carriers of the APOE epsilon 3/epsilon 4 genotype (P = .02, OR = 9.0) and for carriers of the APOE epsilon 4 allele (P = .004, OR = 5.5). Conclusions: The present study is the first to establish a relationship between APOE epsilon 4 and concomitant AD and stroke in the Tunisian population.
引用
收藏
页码:681 / 685
页数:5
相关论文
共 50 条
  • [1] Apolipoprotein E and Alzheimer disease
    Lahoz, C
    Ordovas, JM
    REVISTA CLINICA ESPANOLA, 1997, 197 (02): : 73 - 74
  • [2] Apolipoprotein E and Alzheimer disease
    Huang, YD
    NEUROLOGY, 2006, 66 : S79 - S85
  • [3] Apolipoprotein E and Alzheimer disease
    Growdon, JH
    ARCHIVES OF NEUROLOGY, 1998, 55 (08) : 1053 - 1054
  • [4] Apolipoprotein E and Alzheimer disease
    Roses, AD
    Saunders, AM
    Corder, EH
    Risch, NJ
    Haines, JL
    PericakVance, MA
    Han, SH
    Einstein, G
    Hulette, C
    Schmechel, DE
    Goedert, M
    Jakes, R
    Dong, LM
    Weisgraber, KH
    Holsti, M
    Huang, D
    Strittmatter, WJ
    PRECLINICAL AND CLINICAL STRATEGIES FOR THE TREATMENT OF NEURODEGENERATIVE, CEREBROVASCULAR AND MENTAL DISORDERS, 1996, 11 : 187 - 197
  • [5] Plasma Biomarkers Associated With the Apolipoprotein E Genotype and Alzheimer Disease
    Soares, Holly D.
    Potter, William Z.
    Pickering, Eve
    Kuhn, Max
    Immermann, Frederick W.
    Shera, David M.
    Ferm, Mats
    Dean, Robert A.
    Simon, Adam J.
    Swenson, Frank
    Siuciak, Judith A.
    Kaplow, June
    Thambisetty, Madhav
    Zagouras, Panayiotis
    Koroshetz, Walter J.
    Wan, Hong I.
    Trojanowski, John Q.
    Shaw, Leslie M.
    ARCHIVES OF NEUROLOGY, 2012, 69 (10) : 1310 - 1317
  • [6] Contribution of apolipoprotein E and cathepsin D genotypes to the familial aggregation of Alzheimer's disease
    Heun, R
    Ptok, U
    Kölsch, H
    Maier, W
    Jessen, F
    DEMENTIA AND GERIATRIC COGNITIVE DISORDERS, 2004, 18 (02) : 151 - 158
  • [7] No difference in cerebral glucose metabolism in patients with Alzheimer disease and differing apolipoprotein E genotypes
    Corder, EH
    Jelic, V
    Basun, H
    Lannfelt, L
    Valind, S
    Winblad, B
    Nordberg, A
    ARCHIVES OF NEUROLOGY, 1997, 54 (03) : 273 - 277
  • [8] Genotypes and phenotypes for apolipoprotein E and Alzheimer disease in the Honolulu-Asia Aging Study
    Kardaun, JWPF
    White, L
    Resnick, HE
    Petrovitch, H
    Marcovina, SM
    Saunders, AM
    Foley, DJ
    Havlik, RJ
    CLINICAL CHEMISTRY, 2000, 46 (10) : 1548 - 1554
  • [9] Significance of the apolipoprotein E genotypes in Alzheimer's disease, vascular dementia and coronary artery disease.
    Kandiah, K
    Epstein, D
    Neufeld, R
    Breuer, B
    Mohs, R
    Marin, D
    Rodstein, M
    Libow, LS
    JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1996, 44 (09) : P270 - P270
  • [10] Alzheimer disease and apolipoprotein E.
    Armati, PJ
    Witfiams, KR
    Saunders, AM
    Roses, AD
    BRAIN PATHOLOGY, 1997, 7 (04) : 1039 - 1039